Zimmer Biomet is a leading medical device company based in the United States. It was formed in 2015 through the merger of Zimmer Holdings and Biomet, Inc. The company is headquartered in Warsaw, Indiana.

Zimmer Biomet specializes in orthopedic products and solutions. They offer a wide range of products for joint replacements, including knee and hip replacement systems, as well as products for spinal surgeries, sports medicine, dental implants, and trauma surgeries. Their portfolio also includes surgical tools, biologics, and other related accessories.

The company's products are known for their innovation, quality, and superior patient outcomes. Operating on a global scale, Zimmer Biomet has a strong presence in multiple countries and serves healthcare professionals and patients in over 100 countries worldwide. The company has several notable subsidiaries, including MedTech, a 3D printing company focused on orthopedics, and Biomet 3i, which specializes in dental implant solutions.

Zimmer Biomet also has various joint ventures and partnerships, such as a collaboration with the Mayo Clinic to develop personalized musculoskeletal therapeutic solutions. In terms of market position, Zimmer Biomet is one of the largest players in the orthopedic industry. It competes with other major companies like Johnson & Johnson, Stryker Corporation, and Medtronic.

With a strong global presence and a diverse product portfolio, Zimmer Biomet has achieved significant market success. In 2020, the company reported global sales of approximately $7. 9 billion.

Zimmer Biomet has had several major events and achievements throughout its history. In 2018, the company launched the Persona® Partial Knee System, an innovative solution for partial knee replacement surgeries. They have also made strategic acquisitions, such as the purchase of Biomet, which expanded their product offerings and market reach.

As of the latest information available, Zimmer Biomet continues to be a leading player in the medical device industry. They strive to enhance patient outcomes, drive innovation, and expand their global footprint. The company remains committed to developing new and advanced solutions to meet the evolving needs of the healthcare industry